Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
ClinicalTrials.gov study NCT06094920. IPD Sharing: YES. Countries: 1. Publications: 0.
Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study
ClinicalTrials.gov study NCT02729766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in
ClinicalTrials.gov study NCT05823870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
ClinicalTrials.gov study NCT05614115. IPD Sharing: NO. Countries: 1. Publications: 0.
Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging
ClinicalTrials.gov study NCT06350903. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
ClinicalTrials.gov study NCT03060980. IPD Sharing: NO. Countries: 2. Publications: 0.
Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
ClinicalTrials.gov study NCT05942963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food
ClinicalTrials.gov study NCT06962826. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
ClinicalTrials.gov study NCT04431141. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin Effect on Glucose Toxicity
ClinicalTrials.gov study NCT03437330. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
ClinicalTrials.gov study NCT06642272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The SGLT2 Inhibitor Empagliflozin Enhances Metabolic Efficiency and Ameliorates Left Ventricular Hypertrophy in Myosin R403Q Mutant Hypertrophic Cardiomyopathy Mice
GEO Series GSE270093. Mus musculus. 21 samples. Type: Expression profiling by high throughput sequencing.
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin.
GEO Series GSE134329. Homo sapiens. 7 samples. Type: Expression profiling by high throughput sequencing.
Single nucleus RNA-seq comparison of TYA018 HDAC6 inhibition and Empagliflozin SGLT2 inhibition to treat heart failure with preserved ejection fraction
GEO Series GSE249412. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
SGLT2 Inhibitor Empagliflozin Enhances Metabolic Efficiency and Ameliorates Left Ventricular Hypertrophy in Myosin R403Q Mutant Hypertrophic Cardiomyopathy Mice
GEO Series GSE283722. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg
ClinicalTrials.gov study NCT06232239. IPD Sharing: NO. Countries: 0. Publications: 0.
Cardiovascular Effects of Empagliflozine
ClinicalTrials.gov study NCT02918591. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01984606. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
ClinicalTrials.gov study NCT05140694. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pharmacokinetic Evaluation of Empagliflozin
ClinicalTrials.gov study NCT03059056. IPD Sharing: YES. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.